venous thrombosis

Showing 1 - 25 of 122

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intimate Partner Violence asRisk Factor for Venous

Recruiting
  • Venous Thrombosis
  • WAST questionnaire
  • Nîmes Cedex 09, France
    CHU de Nîmes - Hôpital Universitaire Carémea
Jun 9, 2023

Epidemiology of Venous Thrombosis and Pulmonary Embolism

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
    • (no location specified)
    Nov 14, 2022

    Pulmonary Embolism, Venous Thrombosis Trial in Canada, United States (Enteric Coated Aspirin, Warfarin, Rivaroxaban)

    Recruiting
    • Pulmonary Embolism
    • Venous Thrombosis
    • Enteric Coated Aspirin
    • +2 more
    • Scottsdale, Arizona
    • +30 more
    Nov 3, 2022

    Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)

    Active, not recruiting
    • Venous Thrombosis
    • +2 more
    • 12-month Edoxaban
    • 3-month Edoxaban
    • Kyoto, Japan
      Department of Cardiovascular Medicine, Kyoto University Graduate
    Aug 16, 2022

    Venous Thrombosis, Catheter-Related Infections, Catheter Mechanical Failure Rate Trial in Taipei (Subclavian vein approach,

    Active, not recruiting
    • Venous Thrombosis
    • +2 more
    • Subclavian vein approach
    • internal jugular vein approach
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 15, 2022

    Venous Thromboembolism, Venous Thrombosis, Pulmonary Embolism Trial

    Not yet recruiting
    • Venous Thromboembolism
    • +2 more
      • (no location specified)
      Jun 7, 2022

      Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral

      Completed
      • Venous Thrombosis
      • Neoplasms
      • Heparin, Low-Molecular-Weight, or direct oral anticoagulants
      • Minneapolis, Minnesota
      • +2 more
      Apr 26, 2022

      Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

      Recruiting
      • Cirrhosis
      • +3 more
      • Apixaban 2.5 MG
      • +2 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College, Yangzhou University
      Apr 30, 2022

      Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

      Recruiting
      • Cirrhosis
      • +3 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College of Yangzhou University
      Mar 19, 2022

      Venous Thrombosis, Tumors, Anticoagulants Trial in Kyoto (Long DOAC, Short DOAC)

      Recruiting
      • Venous Thrombosis
      • +2 more
      • Long DOAC
      • Short DOAC
      • Kyoto, Japan
        Department of Cardiovascular Medicine, Kyoto University Graduate
      Mar 29, 2022

      Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

      Recruiting
      • Liver Cirrhosis
      • +4 more
      • Somatostatin and its analogs
      • Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection
      • Shenyang, Liaoning, China
        Department of Gastroenterology, General Hospital of Shenyang Mil
      Mar 17, 2022

      Venous Thrombosis Trial in Worldwide (Shortened duration (6 weeks) of anticoagulant therapy, Conventional duration (3 months) of

      Completed
      • Venous Thrombosis
      • Shortened duration (6 weeks) of anticoagulant therapy
      • +2 more
      • Birmingham, Alabama
      • +62 more
      Mar 1, 2022

      Venous Thrombosis Trial in Shanghai (Rivaroxaban)

      Recruiting
      • Venous Thrombosis
      • Shanghai, China
      • +3 more
      Feb 10, 2022

      Venous Thrombosis Trial in Seoul ([18F]GP1 positron emission tomography/computed tomography)

      Recruiting
      • Venous Thrombosis
      • [18F]GP1 positron emission tomography/computed tomography
      • Seoul, Korea, Republic of
        Asan Medical Center
      Feb 15, 2022

      Perioperative Bleeding, Venous Thrombosis, Arterial Thrombosis Trial in Worldwide (Tranexamic Acid, Placebo (Saline),

      Active, not recruiting
      • Perioperative Bleeding
      • +2 more
      • Tranexamic Acid
      • +3 more
      • New Haven, Connecticut
      • +113 more
      Jan 24, 2022

      Venous Thrombosis, Pregnancy Trial in Houston (antepartum and postpartum)

      Active, not recruiting
      • Venous Thrombosis
      • Pregnancy
      • antepartum and postpartum
      • Houston, Texas
        Baylor College of Medicine
      Dec 7, 2021

      Venous Thrombosis Trial in Bethlehem (Arixtra (Fondaparinox) 2.5 mg SC Daily, Lovenox 40mg SC Daily)

      Terminated
      • Venous Thrombosis
      • Arixtra (Fondaparinox) 2.5 mg SC Daily
      • Lovenox 40mg SC Daily
      • Bethlehem, Pennsylvania
        Lehigh Valley Hospital Muhlenberg
      Oct 14, 2021

      Potential Adverse Outcomes in Routine Clinical Practice

      Completed
      • Venous Thrombosis
      • +3 more
      • Rivaroxaban (Xarelto, Bay59-7939)
      • Standard of care
      • Multiple Locations, Germany
        (unnamed)
      Oct 21, 2021

      Potential Adverse Outcomes in Routine Clinical Pratice

      Completed
      • Venous Thrombosis
      • +3 more
      • Rivaroxoban (Xarelto, Bay59-7939)
      • Standard of care
      • Multiple Locations, Netherlands
        (unnamed)
      Sep 22, 2021

      Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

      Completed
      • Acute Coronary Syndrome
      • +3 more
      • Rivaroxaban (Xarelto, BAY59-7939)
      • Standard of care drugs
      • Multiple Locations, Sweden
        Many Locations
      Sep 22, 2021

      Potential Adverse Outcomes in Routine Clinical Pratice (UK)

      Completed
      • Venous Thrombosis
      • +3 more
      • Rivaroxaban (Xarelto, Bay59-7939)
      • +2 more
      • Multiple Locations, United Kingdom
        (unnamed)
      Sep 22, 2021

      Venous Thrombosis, Arthroplasty, Replacement, Hip Trial (Neuromuscular electrostimulation (NMES) device, Intermittent pneumatic

      Completed
      • Venous Thrombosis
      • Arthroplasty, Replacement, Hip
      • Neuromuscular electrostimulation (NMES) device
      • Intermittent pneumatic compression (IPC) device
      • (no location specified)
      Sep 20, 2021

      Venous Thrombosis Trial (MRI examination)

      Not yet recruiting
      • Venous Thrombosis
      • MRI examination
      • (no location specified)
      Aug 17, 2021

      Venous Thrombosis Trial in Aurora (low dose intravenous heparin (LDIVH), Heparin)

      Completed
      • Venous Thrombosis
      • low dose intravenous heparin (LDIVH)
      • Heparin
      • Aurora, Colorado
        University of Colorado Hospital
      Jul 7, 2021

      Collection of the Thrombo-VaxCov Cohort

      Recruiting
      • Covid19
      • +4 more
      • Retrospective data and biological samples
      • Lille, France
        CHU lille
      May 11, 2021